Drug Trial Radar · NCT02061813
Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion
Last checked: Nov 20, 2026Latest source record: Jul 26, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Jan 2014
Primary completion
Jan 2014
Study completion May 2014
Sponsor
- Lead sponsor
- Dr. Reddy's Laboratories Limited, IndiaIndustry
- Sponsor type
- Industry
- First posted
- Feb 13, 2014
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to determine the irritation potential of repeat applications of abametapir lotion on normal skin.
Conditions
- Head Lice
Interventions
Abametapir Lotion 0.74% w/wDrug
applied 0.2 mL topically under occlusive condition
Sodium Lauryl SulfateDrug
Sodium Lauryl Sulfate is prepared as a 0.2% aqueous solution by the site for topical administration, and applied 21 times over consecutive days under occlusive conditions, will serve as a positive control.
Saline 0.9%Drug
A solution of 0.9% saline for topical administration, applied 21 times over consecutive days under occlusive conditions, will serve as a negative control
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Potential of Abametapir Lotion to Cause Irritation After Repeated Topical Application to the Healthy Skin of Humans.Time frame: 21 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
TKL Reserach Inc
Paramus, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.